Biomedical subjects

V Heitz

Publications and source records attributed to V Heitz.

3 recordsLinked to original sources

PubMed2001

Octahedral Fe(II) and Ru(II) complexes based on a new bis 1,10-phenanthroline ligand that imposes a well defined axis.

A bis-chelating ligand (L1), made of two 7-(p-anisyl)-1,10-phenanthroline (phen) subunits connected with a p-(CH(2))(2)C(6)H(4)(CH(2))(2) spacer through their 4 positions, has been prepared, using Skraup syntheses and reaction of the anion of 4-methyl-7-anisyl-1,10-phenanthroline with alpha,alpha'-dibromo-p-xylene. Its Fe(II) complex, [FeL1(dmbp)](PF(6))(2), was prepared in one step by reaction of L1 with [Fe(dmbp)(3)](PF(6))(2) (dmbp = 4,4'-dimethyl-2,2'-bipyridine). On the other hand, its Ru(II) complex, [RuL1(dmbp)](PF(6))(2), was prepared in two steps from Ru(CH(3)CN)(4)Cl(2) and L1, followed by reaction with dmbp. X-ray crystal structure analyses show that in the two octahedral complexes, ligand L1 coils around the metal by coordination of the axial and two equatorial positions. It defines a 21 A long axis (O.O distance) running through the central metal and the terminal anisyl substituents. The complexes were also characterized by (1)H NMR, mass spectrometry, cyclic voltammetry, electronic absorption, and, in the case of Ru(II), fluorescence spectroscopy.

2,2'-Dipyridyl↗

PubMed2000

A linear multiporphyrinic

A linear multiporphyrinic [2]-rotaxane has been synthesized using the transition metal-templating method for threading a gold(III)-incorporating macrocycle onto a rodlike, phenanthroline-derived chelate bearing carboxylate end groups. Stoppering has been performed by reacting the resulting prerotaxane with the amino derivative of a zinc tetraarylporphyrin under EDC-HOBt activation. A 34% yield has been realized for this one-pot, double amide bond formation.

Journal Article↗

PubMedDate not supplied

Assessment of cortisol response with low-dose and high-dose ACTH in patients with chronic fatigue syndrome and healthy comparison subjects.

A reduced secretion of cortisol has been proposed as a possible explanation of the symptoms in chronic fatigue syndrome. However, the evidence of hypocortisolism in chronic fatigue syndrome is conflicting. In order to simultaneously assess possible alterations in adrenocortical sensitivity and secretory adrenal reserve, the authors administered both low-dose and high-dose ACTH to a group of 18 chronic fatigue syndrome patients and 18 age- and gender-matched healthy comparison subjects. No response differences for salivary and plasma cortisol were detectable after administration of either low-dose or high-dose ACTH, indicating that primary adrenal insufficiency is unlikely to play a significant role in the etiology of chronic fatigue syndrome.

Adrenocorticotropic Hormone↗